These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

426 related articles for article (PubMed ID: 28251017)

  • 1. A Review of Myeloablative vs Reduced Intensity/Non-Myeloablative Regimens in Allogeneic Hematopoietic Stem Cell Transplantations.
    Atilla E; Ataca Atilla P; Demirer T
    Balkan Med J; 2017 Jan; 34(1):1-9. PubMed ID: 28251017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Incidence and Severity of Oral Mucositis among Allogeneic Hematopoietic Stem Cell Transplantation Patients: A Systematic Review.
    Chaudhry HM; Bruce AJ; Wolf RC; Litzow MR; Hogan WJ; Patnaik MS; Kremers WK; Phillips GL; Hashmi SK
    Biol Blood Marrow Transplant; 2016 Apr; 22(4):605-616. PubMed ID: 26409924
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Defining the intensity of conditioning regimens: working definitions.
    Bacigalupo A; Ballen K; Rizzo D; Giralt S; Lazarus H; Ho V; Apperley J; Slavin S; Pasquini M; Sandmaier BM; Barrett J; Blaise D; Lowski R; Horowitz M
    Biol Blood Marrow Transplant; 2009 Dec; 15(12):1628-33. PubMed ID: 19896087
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Progress of research on allogeneic hematopoietic stem cell transplantation with reduced-intensity conditioning regimen for treatment of myelodysplastic syndrome - review].
    Zhang Z; Li X
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2008 Aug; 16(4):969-74. PubMed ID: 18718102
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antithymocyte globulin in reduced-intensity conditioning regimen allows a high disease-free survival exempt of long-term chronic graft-versus-host disease.
    Devillier R; Fürst S; El-Cheikh J; Castagna L; Harbi S; Granata A; Crocchiolo R; Oudin C; Mohty B; Bouabdallah R; Chabannon C; Stoppa AM; Charbonnier A; Broussais-Guillaumot F; Calmels B; Lemarie C; Rey J; Vey N; Blaise D
    Biol Blood Marrow Transplant; 2014 Mar; 20(3):370-4. PubMed ID: 24315846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment of lymphoid malignancies with non-myeloablative stem cell transplantation.
    Seftel MD; Lavoie J; Barnett MJ; Conneally E
    Hematology; 2002 Jun; 7(3):151-5. PubMed ID: 12243977
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conventional versus reduced-intensity conditioning regimen for allogeneic stem cell transplantation in patients with hematological malignancies.
    Valcárcel D; Martino R; Sureda A; Canals C; Altés A; Briones J; Sanz MA; Parody R; Constans M; Villela SL; Brunet S; Sierra J
    Eur J Haematol; 2005 Feb; 74(2):144-51. PubMed ID: 15654906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparative outcome of reduced intensity and myeloablative conditioning regimen in HLA identical sibling allogeneic hematopoietic stem cell transplantation for acute leukemia patients: a single center experience.
    Goker H; Ozdemir E; Uz B; Buyukasik Y; Turgut M; Serefhanoglu S; Aksu S; Sayinalp N; Haznedaroglu IC; Tekin F; Karacan Y; Unal S; Eliacik E; Isik A; Ozcebe OI
    Transfus Apher Sci; 2013 Dec; 49(3):590-9. PubMed ID: 23981652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of outcomes after two standards-of-care reduced-intensity conditioning regimens and two different graft sources for allogeneic stem cell transplantation in adults with hematologic diseases: a single-center analysis.
    Le Bourgeois A; Mohr C; Guillaume T; Delaunay J; Malard F; Loirat M; Peterlin P; Blin N; Dubruille V; Mahe B; Gastinne T; Le Gouill S; Moreau P; Mohty M; Planche L; Lode L; Bene MC; Chevallier P
    Biol Blood Marrow Transplant; 2013 Jun; 19(6):934-9. PubMed ID: 23523970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic stem cell transplantation for adults with myelodysplastic syndromes: importance of pretransplant disease burden.
    Warlick ED; Cioc A; Defor T; Dolan M; Weisdorf D
    Biol Blood Marrow Transplant; 2009 Jan; 15(1):30-8. PubMed ID: 19135940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Similar outcomes using myeloablative vs reduced-intensity allogeneic transplant preparative regimens for AML or MDS.
    Luger SM; Ringdén O; Zhang MJ; Pérez WS; Bishop MR; Bornhauser M; Bredeson CN; Cairo MS; Copelan EA; Gale RP; Giralt SA; Gulbas Z; Gupta V; Hale GA; Lazarus HM; Lewis VA; Lill MC; McCarthy PL; Weisdorf DJ; Pulsipher MA
    Bone Marrow Transplant; 2012 Feb; 47(2):203-11. PubMed ID: 21441963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allogeneic hematopoietic stem cell transplantation in elderly].
    Castagna L; Blaise D; Furst S
    Bull Cancer; 2011 Aug; 98(8):915-25. PubMed ID: 21835732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of "minitransplantation": nonmyeloablative allogeneic hematopoietic stem cell transplantation.
    Georges GE; Storb R
    Int J Hematol; 2003 Jan; 77(1):3-14. PubMed ID: 12568294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allogeneic hematopoietic stem cell transplantation (HSCT) after reduced intensity conditioning.
    Servais S; Baron F; Beguin Y
    Transfus Apher Sci; 2011 Apr; 44(2):205-10. PubMed ID: 21345734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hematological malignancies with allogeneic nonmyeloablative stem cell transplantation: conditioning regimens with fludarabine.
    Carella AM
    Hematol J; 2004; 5 Suppl 1():S68-75. PubMed ID: 15079155
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogeneic stem cell transplantation for patients with advanced hematological malignancies: comparison of fludarabine-based reduced intensity conditioning versus myeloablative conditioning.
    Kim I; Lee KH; Choi Y; Keam B; Koo NH; Yoon SS; Yoo KY; Park S; Kim BK
    J Korean Med Sci; 2007 Apr; 22(2):227-34. PubMed ID: 17449929
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Reduced intensity allogenic hematopoietic stem cell transplantation in children].
    Paillard C; Lutz P; Michel G; Leverger G; Dalle JH; Demeocq F; Kanold J
    Bull Cancer; 2011 May; 98(5):541-8. PubMed ID: 21576045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced-intensity conditioning in allogeneic stem cell transplantation for hematological malignancies: a historical perspective.
    Cremer B; Sandmaier BM; Bethge W; Lange T; Goede V; Holtick U; Hallek M; Hübel K
    Onkologie; 2011; 34(12):710-5. PubMed ID: 22156452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Allogeneic hematopoietic stem cell transplantation in Philadelphia-negative adult ALL: myeloablative, non-myeloablative, and beyond.
    Hwang YY; Mohty M; Chim CS
    Hematology; 2015 Mar; 20(2):61-71. PubMed ID: 24993587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.